U.S. doctors online nowAsk doctors free
A 47-year-old member asked:

What is the molecular structure of alemtuzumab? how does it work?

2 doctor answers3 doctors weighed in
Dr. Sameh Abuerreish
Hematology and Oncology 28 years experience
Monoclonal antibody: Campath (alemtuzumab) -1H it is a monoclonal antibody ( immunoglobulin structure) a large protein that binds to CD 52 , a surface receptor on mature lymphocytes. The CD 52 bearing lymphocytes will be targeted for destruction This makes it a drug useful to treat CLL ,(chronic lymphocytic leukemia ) Was withdraw from the markets in 2012 to prepare for a launch of a more expensive drug to treat MS
Dr. Joseph Torkildson
Pediatric Hematology and Oncology 40 years experience
Anti-leukemia drug: This is hard to explain in 400 characters, but here is a website with a good explanation of the drug, it's uses, how it works, and other useful information. http://chemocare.com/chemotherapy/drug-info/alemtuzumab.aspx

Related questions

A 35-year-old member asked:
1 doctor answer1 doctor weighed in
A 52-year-old member asked:
1 doctor answer3 doctors weighed in
A 43-year-old member asked:
1 doctor answer1 doctor weighed in
A 22-year-old female asked:
2 doctor answers3 doctors weighed in
A 41-year-old member asked:
2 doctor answers3 doctors weighed in
Last updated Dec 10, 2014
Connect with a U.S. board-certified doctor by text or video anytime, anywhere.
24/7 visits - just $39!
50% off with $15/month membership

Disclaimer:

Content on HealthTap (including answers) should not be used for medical advice, diagnosis, or treatment, and interactions on HealthTap do not create a doctor-patient relationship. Never disregard or delay professional medical advice in person because of anything on HealthTap. Call your doctor or 911 if you think you may have a medical emergency.